Search results
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 6 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Kobach sues Pfizer over COVID vaccine claims
KSNW Wichita via Yahoo News· 6 days agoKansas Attorney General Kris Kobach has filed a lawsuit against Pfizer. He says the company made misleading and deceptive claims about its COVID-19 ...
Kansas AG joins with Texas to become second state to sue Pfizer over COVID-19 vaccine
BizPac Review· 5 days agoKansas Attorney General Kris Kobach announced on Monday that he was suing the pharmaceutical company Pfizer over the COVID-19 vaccine, becoming the second ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Merck’s vaccine approval poses threat to one of Pfizer’s top-selling products
Market Watch· 6 days ago“We’ll provide protection that’s broader than anything that’s out there,” Art Hirt, senior vice...
Kansas attorney general sues Pfizer over COVID vaccine, company responds
KSNT Topeka via Yahoo News· 6 days agoRelated video: Class action lawsuits – what are they, and should you join one? TOPEKA (KSNT) –...
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading...
Benzinga· 6 days agoPFE, accusing the company of violating consumer protection laws related to its COVID-19 vaccine. Kansas Attorney General Kris Kobach argues that Pfizer ...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 1 day agoEven if that target proves overly optimistic, much of the negative impact of the patent cliff could be offset by these new products and indications. ...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 4 days agoThe most important is that most respondents have no way of knowing whether an acquaintance's death...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoModerna will rival Pfizer and GSK, which launched their shots last year. Also, in June, Moderna and...